TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions: Treatment of tRCC cell lines with the mitochondrial Complex I inhibitor rotenone led to an increased NADH/NAD+ ratio by SoNar, as did knockout of TFE3 fusions (Fig. 3j and Extended Data Fig. 4i).